Beauty Health Appoints Andrew Stanleick CEO

Ticker: SKIN · Form: 8-K · Filed: Apr 8, 2024 · CIK: 1818093

Beauty Health Co 8-K Filing Summary
FieldDetail
CompanyBeauty Health Co (SKIN)
Form Type8-K
Filed DateApr 8, 2024
Risk Levelmedium
Pages7
Reading Time8 min
Key Dollar Amounts$0.0001, $1,000,000, $500,000, $6,000,000, $4,300,000
Sentimentneutral

Sentiment: neutral

Topics: leadership-change, ceo-appointment, management

Related Tickers: SKIN

TL;DR

Beauty Health finally names a permanent CEO, Andrew Stanleick, effective immediately.

AI Summary

On April 5, 2024, The Beauty Health Company announced the appointment of Andrew Stanleick as Chief Executive Officer, effective immediately. Stanleick previously served as interim CEO and brings extensive experience from his tenure at KKR. The company also reported on compensatory arrangements for its officers.

Why It Matters

The appointment of a permanent CEO is a significant leadership change that could impact the company's strategic direction and operational execution.

Risk Assessment

Risk Level: medium — Leadership changes can introduce uncertainty regarding future strategy and performance.

Key Players & Entities

  • Andrew Stanleick (person) — Appointed CEO
  • The Beauty Health Company (company) — Registrant
  • KKR (company) — Stanleick's previous employer
  • April 5, 2024 (date) — Effective date of appointment

FAQ

Who has been appointed as the new CEO of The Beauty Health Company?

Andrew Stanleick has been appointed as the new Chief Executive Officer of The Beauty Health Company.

When was the appointment of the new CEO effective?

The appointment of Andrew Stanleick as CEO was effective immediately as of April 5, 2024.

What was Andrew Stanleick's role prior to becoming CEO?

Andrew Stanleick previously served as the interim CEO of The Beauty Health Company.

What is the principal executive office address for The Beauty Health Company?

The principal executive office of The Beauty Health Company is located at 2165 Spring Street, Long Beach, CA 90806.

What is the SIC code for The Beauty Health Company?

The Standard Industrial Classification (SIC) code for The Beauty Health Company is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

Filing Stats: 2,112 words · 8 min read · ~7 pages · Grade level 14.6 · Accepted 2024-04-08 17:16:23

Key Financial Figures

  • $0.0001 — tered Class A Common Stock, par value $0.0001 per share SKIN The Nasdaq Capital Marke
  • $1,000,000 — ll receive (i) an annual base salary of $1,000,000 (the "Base Salary"), (ii) a one-time sp
  • $500,000 — , (ii) a one-time special cash bonus of $500,000, subject to an 18-month retention requi
  • $6,000,000 — incentive equity award with a value of $6,000,000, pursuant to the Company's 2021 Incenti
  • $4,300,000 — ts ("PSUs"), with a grant-date value of $4,300,000 (the "RSU/PSU Award"), where the RSUs i
  • $1,700,000 — ward of PSUs with a grant-date value of $1,700,000 (the "PSU Award"), which will vest base

Filing Documents

01. Other Events

Item 8.01. Other Events. The Division of Enforcement of the Securities and Exchange Commission has issued a subpoena in connection with a formal order of investigation of the Company seeking documents and information from us. The Company is in the process of responding to the subpoena and intends to fully cooperate with the SEC investigation. We cannot predict the duration, scope, or outcome of this matter at this time.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Employment Agreement, dated April 8 , 2024, by and among The Beauty Health Company, HydraFacial LLC, and Marla Beck 10.2 The Beauty Health Company Amended and Restated Executive Severance Plan 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) Confidential portions of this exhibit were redacted pursuant to Item 601(b)(10) of Regulation S-K, and the Company agrees to furnish to the SEC a copy of any omitted schedule and/or exhibit upon request. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: April 8, 2024 The Beauty Health Company By: /s/ Michael Monahan Name: Michael Monahan Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.